Skip to main content
All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for HALEON US HOLDINGS LLC · consumer health care company

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income · posted Apr 20, 2026

Official filing document

 Bills named in this filing 3
  • HR 5166
    Financial Services and General Government Appropriations Act, 2026
  • S 3290
    Financial Services and General Government Appropriations Act, 2026
  • HR 7148
    Consolidated Appropriations Act, 2026
 Lobbying activity 5
Taxation/Internal Revenue Code

Issues related to coverage of over-the-counter products with FSAs and HSAs.

Budget/Appropriations

Policies impacting access to over-the-counter products; FY2026 Financial Services and General Government Appropriations Act process (H.R.5166/S.3290); H.R.7148, Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes (P.L.119-75).

Trade (domestic/foreign)

Policies impacting the supply chain and manufacturing of over-the-counter pharmaceutical products including tariffs.

Medicare/Medicaid

Education about the importance of OTC products and benefits under Medicare Advantage.

Health Issues

Issues related to healthcare and payment for over-the-counter drugs; General education of over-the-counter switches, including reauthorization of the Over-the-Counter Monograph Drug User Fee Act and policies impacting a Nonprescription Drug Product with an Additional Condition for Nonprescription Use.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem